We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ADC Therapeutics Licenses Proprietary Antibodies from Five Prime Therapeutics

News   Nov 07, 2013

 
ADC Therapeutics Licenses Proprietary Antibodies from Five Prime Therapeutics
 
 
 

RELATED ARTICLES

Protein Curbs Obesity Through Our Gut Bacteria

News

Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.

READ MORE

Genetic Similarities Found Across Multiple Cancer Types

News

Study could lead to new treatments for advanced epithelial cancers such as lung and prostate cancers.

READ MORE

Observing Cancer Cell Behavior

News

A new cell culture platform allows researchers to observe never-before-seen behaviors of live cancer cells under the microscope, leading to explanations of long-known cancer characteristics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE